arrow_back Back to App

Extension and Expansion of National Alzheimer's Project

This act extends the National Alzheimer's Project until 2035, strengthening efforts for healthy aging and reducing dementia risk. Citizens will gain access to broader information on prevention and support, as well as better coordination of public and private efforts in combating Alzheimer's disease.
Key points
The National Alzheimer's Project will continue until 2035, ensuring long-term support for research and initiatives related to the disease.
Increased focus on promoting healthy aging and reducing risk factors for Alzheimer's disease, potentially aiding in prevention.
More government agencies, including the Department of Justice and FEMA, will join the advisory committee, improving coordination.
An individual diagnosed with Alzheimer's disease will be included in the advisory committee, providing a patient perspective.
Annual evaluations of progress in research and public health efforts, including risk reduction and addressing disparities in care.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_7775
Sponsor: Rep. Tonko, Paul [D-NY-20]
Process start date: 2022-05-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

NAPA Reauthorization Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7775.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-13.

What are the main provisions?

Key points include:

  • The National Alzheimer's Project will continue until 2035, ensuring long-term support for research and initiatives related to the disease.
  • Increased focus on promoting healthy aging and reducing risk factors for Alzheimer's disease, potentially aiding in prevention.
  • More government agencies, including the Department of Justice and FEMA, will join the advisory committee, improving coordination.
  • An individual diagnosed with Alzheimer's disease will be included in the advisory committee, providing a patient perspective.
  • Annual evaluations of progress in research and public health efforts, including risk reduction and addressing disparities in care.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Tonko, Paul [D-NY-20].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health